Our results revealed that CD19hi B cells in the periphery of SLE and pemphigus patients as well as in human tonsils exhibited an activated phenotype, demonstrated by the upregulation of HLA-DR, IgG and IgM expression. This evidence concerns the gene CD40LG and pemphigus.